About Nanotether
Nanotether is a company based in Cardiff (United Kingdom) founded in 2012 was acquired by Belluscura in April 2017. Nanotether has raised $4.06 million across 1 funding round from investors including Belluscura and IP Group. Nanotether operates in a competitive market with competitors including Phoremost, Rheonix, 64x Bio, reMYND and Molcure, among others.
- Headquarter Cardiff, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.06 M (USD)
in 1 rounds
-
Latest Funding Round
$4.06 M (USD), Series A
Jun 01, 2012
-
Investors
Belluscura
& 1 more
-
Employee Count
Not available
-
Acquired by
Belluscura
(Apr 25, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Nanotether
Nanotether has successfully raised a total of $4.06M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.06 million completed in June 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nanotether
Nanotether has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Belluscura and IP Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and advisory services are offered across multiple sectors.
|
Locked | Locked | Locked | |
|
Provider of medical devices for laparoscopic procedures
|
Locked | Locked | Locked |
Investor details for Nanotether
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nanotether
Investment portfolio details for Nanotether
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nanotether
Detailed financials for Nanotether
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nanotether Comparisons
Peer comparison for Nanotether
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nanotether
Nanotether operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Phoremost, Rheonix, 64x Bio, reMYND and Molcure, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Phenotypic screening platform developed to identify drug targets and pathways.
|
|
| Locked | Locked | Locked |
Instruments for automated molecular assays are developed using disposable cartridges.
|
|
| Locked | Locked | Locked |
Cell and gene therapies for multiple diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of a drug pipeline programs for neurodegenerative diseases
|
|
| Locked | Locked | Locked |
AI-based platform for drug discovery and antibody detection is provided.
|
|
| Locked | Locked | Locked |
Protein design, synthesis, testing, and validation services are offered.
|
Detailed competitors of Nanotether
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nanotether
Complete news archive for Nanotether
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nanotether
Nanotether was founded in 2012.
Nanotether is headquartered in Cardiff, United Kingdom. It is registered at Cardiff, Wales, United Kingdom.
Nanotether is a funded company, having raised a total of $4.06M across 1 funding round to date.
Nanotether was founded in 2012 in Cardiff, United Kingdom, and operates in the biotechnology sector focused on drug discovery. Variable-length DNA molecules are utilized as tethers to bind test molecules in proximity, enabling miniaturized biological assays with reduced material needs. This approach supports high-throughput screening programs by addressing efficiency challenges in traditional methods.
Nanotether has 2 investors. Key investors include Belluscura, and IP Group.